Differential effects of AT1 receptor and Ca2+ channel blockade on atherosclerosis, inflammatory gene expression, and production of reactive oxygen species-Reference-Cited by-同舟云学术

Differential effects of AT1 receptor and Ca2+ channel blockade on atherosclerosis, inflammatory gene expression, and production of reactive oxygen species

Published:2007-11 Issue:1 Volume:195 Page:39-47
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Doran Derek E.,Weiss Daiana,Zhang Yong,Griendling Kathy K.,Taylor W. Robert

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference56 articles.

1. Angiotensin II and atherosclerosis;Weiss;Am J Cardiol,2001

2. Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice;Weiss;Circulation,2001

3. Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor −/− mice;Daugherty;Ann N Y Acad Sci,1999

4. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice;Daugherty;J Clin Invest,2000

5. Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta;Ihara;Hypertension,1999

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ERAP1 shows distinct regulatory mechanisms on blood pressure modulation between males and females;2023-06-09

2. Interaction of Vitamin D with Peptide Hormones with Emphasis on Parathyroid Hormone, FGF23, and the Renin-Angiotensin-Aldosterone System;Nutrients;2022-12-06

3. Coexistence effect of hypertension and angiotensin II on the risk of coronary heart disease: a population-based prospective cohort study among Inner Mongolians in China;Current Medical Research and Opinion;2019-05-03

4. Gene Expression in the Hippocampus in a Rat Model of Premenstrual Dysphoric Disorder After Treatment With Baixiangdan Capsules;Frontiers in Psychology;2018-11-13

5. Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease;Pharmacological Research;2017-11